To Top

Mar. 11, 2022

TOPIC: Advocacy

FDA’s Accelerated Approval Pathway: A Rare Disease Perspective

Posted by Valaree DonFrancesco

Accelerated approval is critical to providing access to new, safe, and effective drugs to patients with serious and life-threatening diseases and conditions for which there are no meaningful alternatives. Learn more about the history of accelerated approval, how its use has benefited rare disease patients, and recommendations for strengthening the accelerated approval pathway by clicking here.